# Accelerate Diagnostics

its Accelerate Pheno system runs rapid phenotypic antibiotic susceptibility testing directly from a positive blood culture, with clinical performance documented across multiple peer-reviewed studies.

Source: https://en.bioecon.ru/companies/accelerate-diagnostics/
Updated: 2026-07-20

- Country: United States
- Ticker: AXDX

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | $11.7 million for the year ended December 31, 2024 (2024-12-31) | https://last10k.com/sec-filings/axdx/0001628280-25-014205.htm |
| Headcount | approximately 107 full-time employees worldwide (2024-12-31) | http://www.annualreports.com/Click/23618 |
| Production site | Tucson, Arizona | http://www.annualreports.com/Click/23618 |
| Regulatory approval | FDA de novo clearance for Accelerate Pheno system and PhenoTest BC Kit (2017) | https://www.sec.gov/Archives/edgar/data/727207/000110465923125787/tm2332697-1_s1.htm |
| Regulatory approval | FDA 510(k) clearance for Accelerate Arc system and BC kit (2024) | https://last10k.com/sec-filings/axdx/0001628280-25-014205.htm |
| Certification | CE mark for Accelerate Pheno system and PhenoTest BC kit (2015) | https://www.sec.gov/Archives/edgar/data/727207/000110465923125787/tm2332697-1_s1.htm |
| Certification | CE IVDR registration for Accelerate Arc system and BC kit (2022) | https://www.sec.gov/Archives/edgar/data/727207/000110465923125787/tm2332697-1_s1.htm |

Independent sources: annualreports.com, last10k.com, sec.gov

## Technologies

- [Rapid antibiotic-resistance tests](https://en.bioecon.ru/technology/rapid-antibiotic-resistance-tests/)